MARKETS

BSE Prices delayed by 5 minutes... Prices as on Sep 21, 2018   ABB India 1433.95 [ -0.18% ]ACC 1541.65 [ -1.32% ]Ambuja Cements Ltd. 225.3 [ 0.11% ]Asian Paints Ltd. 1303.1 [ 1.07% ]Axis Bank Ltd. 599.4 [ -1.61% ]Bajaj Auto Ltd. 2795.65 [ 0.01% ]Bank of Baroda 111.65 [ -4.00% ]Bharti Airtel 372.4 [ 0.73% ]Bharat Heavy Ele 71.5 [ -4.16% ]Bharat Petroleum 375.1 [ 2.74% ]Britannia Ind. 5780.55 [ -2.95% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 660.6 [ 0.17% ]Coal India 275.65 [ -1.75% ]Colgate Palm. 1106.75 [ -0.93% ]Dabur India 456.1 [ -2.07% ]DLF Ltd. 198.75 [ -1.27% ]Dr. Reddy's Labs 2562.9 [ -1.57% ]GAIL (India) Ltd. 389.45 [ 1.35% ]Grasim Inds. 1048.4 [ -1.75% ]HCL Technologies 1084.6 [ -0.25% ]HDFC 1835.25 [ 0.22% ]HDFC Bank 1968.85 [ 0.35% ]Hero MotoCorp 3165.7 [ 0.74% ]Hindustan Unilever L 1621.65 [ -1.65% ]Hindalco Indus. 240.35 [ 1.86% ]ICICI Bank 317.8 [ -0.95% ]IDFC L 44.65 [ -6.98% ]Indian Hotels Co 126.85 [ -1.28% ]IndusInd Bank 1761.7 [ -2.38% ]Infosys 706.3 [ -1.96% ]ITC Ltd. 303.75 [ 1.37% ]Jindal St & Pwr 234.35 [ 0.75% ]Kotak Mahindra Bank 1179.65 [ -3.86% ]L&T 1331.75 [ -0.04% ]Lupin Ltd. 889.75 [ -2.12% ]Mahi. & Mahi 957.2 [ 1.05% ]Maruti Suzuki India 8039.55 [ -2.04% ]MTNL 15.15 [ -3.19% ]Nestle India 9765.15 [ -3.82% ]NIIT Ltd. 86.1 [ -4.12% ]NMDC Ltd. 115.7 [ -1.99% ]NTPC 167.35 [ -1.03% ]ONGC 180.1 [ 1.95% ]Punj. NationlBak 72.8 [ -8.20% ]Power Grid Corpo 200.2 [ 1.03% ]Reliance Inds. 1216.85 [ 0.54% ]SBI 270.05 [ -0.50% ]Vedanta 229.7 [ -0.13% ]Shipping Corpn. 47.55 [ -4.33% ]Sun Pharma. 635.5 [ -1.82% ]Tata Chemicals 735.05 [ -0.57% ]Tata Global Beverage 234.05 [ -0.17% ]Tata Motors Ltd. 250.2 [ -0.99% ]Tata Steel 624.55 [ 0.66% ]Tata Power Co. 72.8 [ -3.51% ]Tata Consultancy 2103.8 [ 1.30% ]Tech Mahindra Ltd. 745.35 [ -3.19% ]UltraTech Cement 4077.95 [ 0.68% ]United Spirits 537.6 [ -4.12% ]Wipro Ltd 337.35 [ 1.38% ]Zee Entertainment En 452.1 [ 0.04% ]

News Details

You can view in detail.
Lupin launches Tobramycin Inhalation Solution in US 14/06/2018 09:25

Pharma major Lupin has said that it has launched Tobramycin Inhalation Solution USP, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Tobramycin Inhalation Solution USP, 300 mg/5 ml is the generic equivalent of Novartis Pharmaceuticals Corporation's Tobis 300 mg/5 ml.

It is indicated for the management of cystic fibrosis patients with P. aeruginosa. Tobramycin Inhalation Solution USP, 300 mg/5 ml had annual sales of approximately USD 99 million in the US (IQVIA MAT April 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.

Meanwhile, shares of the company were trading at Rs 875.95 apiece up 0.73 per cent from the previous close at 09:25 hrs on BSE.

LOAD MORE